Columbia Research Enhanced Value ETF (NYSEARCA:REVS) Sees Large Growth in Short Interest

Columbia Research Enhanced Value ETF (NYSEARCA:REVS) was the target of a large growth in short interest during the month of August. As of August 14th, there was short interest totaling 44,970 shares, a growth of 61.3% from the July 30th total of 27,888 shares. Approximately 0.4% of the company’s stock are short sold. Based on an average daily trading volume, of 41,985 shares, the days-to-cover ratio is presently 1.1 days.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of REVS. NewEdge Advisors LLC increased its position in shares of Columbia Research Enhanced Value ETF by 13.4% during the 2nd quarter. NewEdge Advisors LLC now owns 122,687 shares of the company’s stock valued at $3,224,000 after purchasing an additional 14,498 shares during the last quarter. Raymond James Financial Inc. boosted its holdings in shares of Columbia Research Enhanced Value ETF by 396.4% in the 2nd quarter. Raymond James Financial Inc. now owns 200,098 shares of the company’s stock worth $5,259,000 after buying an additional 159,786 shares during the last quarter. Private Advisor Group LLC bought a new position in Columbia Research Enhanced Value ETF during the third quarter valued at about $448,000. World Investment Advisors purchased a new stake in Columbia Research Enhanced Value ETF during the fourth quarter worth about $1,169,000. Finally, Essex Financial Services Inc. increased its holdings in Columbia Research Enhanced Value ETF by 108.5% during the fourth quarter. Essex Financial Services Inc. now owns 24,626 shares of the company’s stock worth $697,000 after buying an additional 12,815 shares during the last quarter.

Columbia Research Enhanced Value ETF Stock Performance

REVS traded up $0.17 during mid-day trading on Wednesday, reaching $33.98. 21,919 shares of the stock were exchanged, compared to its average volume of 51,206. The stock has a market capitalization of $339.80 million, a PE ratio of 16.41 and a beta of 0.79. The company has a 50 day moving average price of $33.09 and a two-hundred day moving average price of $31.16. Columbia Research Enhanced Value ETF has a 1 year low of $27.24 and a 1 year high of $34.23.

About Columbia Research Enhanced Value ETF

The Columbia Research Enhanced Value ETF (REVS) is an exchange-traded fund that mostly invests in large cap equity. The fund tracks an index of US stocks pulled from the Russell 1000 Value Index. REVS index uses multifactor selection and market cap weighting. REVS was launched on Sep 25, 2019 and is managed by Columbia.